Elan Drug Technologies

Navigation

• Home
• Careers
• Sitemap

Enhanced Oral Bioavailaibility

Elan Drug Technologies’ NanoCrystal^® technology can help improve the bioavailability of a compound and bring a significant number of practical benefits.

These benefits include:

• reduction in required dose
• reduction in fed/fasted variability
• improved dose proportionality
• smaller dosage forms
• more convenient dosage forms

Examples of enhanced bioavailability with NanoCrystal^® technology

This graph illustrates how notably greater plasma concentrations may be achieved by NanoCrystal^® formulations in comparison to conventional formulations.

This plot shows the variation in bioavailability with particle size. This demonstrates the improved bioavailability performance that can be achieved by reducing the particle size with NanoCrystal^® technology.